In recent decades, several new early biomarkers for sepsis have been tested, such as matrix metalloproteinase-9 (MMP-9), its endogenous inhibitor tissue inhibitor of metalloproteinase-1 (TIMP-1), and mid-regional pro-adrenomedullin (MR-proADM). This evidence concerns the gene ADM and Sepsis.